A study showed that the cell viabilities of lung cancer cell lines could be significantly abrogated by the overexpression of PANDAR, which was shown to detain and disable the Bcl-2 transcription factor Nuclear Transcription Factor Y Subunit Alpha (NF-YA) (52). The gene discussed is NFYA; the disease is lung carcinoma.